Lightning Talk: Innovating the Future of Biologics R&D

Disruptive Organ-on-Chip Models for Predictive Drug Permeation, Toxicity, and Efficacy Testing

Discover how next-generation gut-on-chip and skin-on-chip models are reshaping preclinical research. Using the patented MIVO® millifluidic platform, we’ve developed dynamic human tissue systems that accurately mimic physiological conditions, offering powerful alternatives to in vivo testing. Our dual-flow gut model achieves full intestinal differentiation in less than 14 days, enables precise control over barrier function and mucus production, finally increasing the reliability and predictability of drug permeation. Integrated with a 3D skin model, our multi-organ system simulates the gut–skin axis, revealing how oral treatments like probiotics can improve skin hydration through microbiota modulation. This talk will explore how these validated platforms accelerate drug screening, support microbiome-based therapies, and bridge the translational gap—delivering scalable, ethical, and regulatory-ready solutions for pharma and dermocosmetic innovation.